The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s veterinary anti infectives market report forecasts the veterinary anti infectives market size to grow to $7 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Veterinary Anti Infectives Market Report 2023 – https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Anti Infectives Market Size Forecast
The global veterinary anti infectives market is expected to grow from $4.64 billion in 2022 to $5.08 billion in 2023 at a compound annual growth rate (CAGR) of 9.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary anti-infectives market size is expected to grow to $7 billion in 2027 at a CAGR of 8.3%.

North America held the largest veterinary anti infectives market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Veterinary Anti Infectives Market Driver ­– Increase In Pet Ownership
For instance, according to South China Morning Post, a Hong Kong-based English-language newspaper, pet owners in China have reached 62.94 million in 2020 – up from 62.8 million in 2019. Therefore, an increase in pet ownership is driving the demand for veterinary anti-infectives market.

Request for A Sample Of The Global Veterinary Anti Infectives Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Key Veterinary Anti Infectives Market Trend – Technological Advancement
Major companies operating in the market are using advanced technologies to sustain their position in the veterinary anti-infectives market. For instance, in February 2021, Elanco Animal Health Incorporated, a US-based pharmaceutical company that manufactures drugs and vaccinations for pets and livestock launched Increxxa, the newly approved drug for livestock respiratory disease. Increxxa with its key ingredient being tulathromycin is delivered to the livestock in injection and targets the lungs’ site of infection swiftly for fast action and a lengthy half-life, providing cattle more time to establish a strong defense. This product is designed for veterinary use and tulathromycin, the active ingredient in Increxxa, helps decrease the negative effects of bovine respiratory disease.

Veterinary Anti Infectives Market Segment
1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes
2) By Species Type: Livestock Animals, Companion Animals
3) By Mode Of Administration: Oral, Parenteral, Topical
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Veterinary Anti Infectives Market Major Players and Strategies
Major players in the veterinary anti infectives market are Bayer AG, Boehringer Ingelheim, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol, Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals, Intervet International B.V., Oceanic Pharmachem, Virbac Ltd., Indian Immunologicals Ltd (IIL), Norbrook Laboratories, and Ashish Life Science.

In June 2022, Ceva Santé Animale, a France-based multinational animal health company, acquired Artemis Technologies, Inc for an undisclosed amount. This acquisition complements Ceva’s rabies portfolio and extensive knowledge of the development of oral rabies vaccines and campaign management in Europe and other regions. Ceva will increase its market footprint in North America with this acquisition. Artemis Technologies, Inc is a Canada-based oral rabies vaccine manufacturer.

The Veterinary Anti Infectives Global Market Report 2023 covers regional data on veterinary anti infectives market size, veterinary anti infectives market trends and drivers, opportunities, strategies, and veterinary anti infectives market competitor analysis. The countries covered in the veterinary anti infectives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The term veterinary anti-infective refers to a broad category where animals are cared for by providing both illness prevention and cure approaches.

View More Reports Related To The Veterinary Anti Infectives Market –
Veterinary Infectious Disease Diagnostics Global Market Report 2023
AntiHypertensive Drugs Global Market Report 2023
Veterinary Patient Monitoring Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: